MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Clinical trials for MULTIPLE SCLEROSIS, RELAPSING-REMITTING explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS, RELAPSING-REMITTING trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, RELAPSING-REMITTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Old allergy pill shows promise in repairing MS nerve damage
Disease control CompletedThis study tested whether clemastine, an older allergy medicine, could help repair the protective coating (myelin) around nerves in people with relapsing multiple sclerosis (MS). Fifty participants with MS and evidence of nerve damage in their vision took either clemastine or a p…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
German study tracks Real-Life impact of MS pill on Patients' lives
Disease control CompletedThis study observed 450 people with relapsing multiple sclerosis in Germany who were already prescribed ozanimod (Zeposia) by their doctor. Over three years, it tracked how long patients stayed on the medication, how well it controlled their MS symptoms, and how it affected their…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Doctors track MS patients switching to newer pill therapy
Disease control CompletedThis study observed 104 people with relapsing-remitting multiple sclerosis (RRMS) in Italy who switched from their first or second disease-modifying therapy to a newer oral medication called ozanimod. Researchers tracked why patients switched (like side effects or the treatment n…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists map brain damage to unlock MS walking mystery
Knowledge-focused CompletedThis study aimed to better understand how specific brain and spinal cord damage affects walking problems in people with multiple sclerosis (MS). Researchers used detailed MRI scans and walking tests on 94 adults with relapsing-remitting MS to see if damage to certain nerve pathwa…
Matched conditions: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC